WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 25'9301 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 30'7341 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 1'170  1'161  1'152  1'144  1'135  943  767  685 
Births 13  13  13  13  13  12  15  14 
Surviving infants 13  13  13  13  13  12  15  13 
Pop. less than 5 years 66  66  66  66  65  68  70  60 
Pop. less than 15 years 197  196  196  197  197  211  195  171 
Female 15-49 years 306  307  306  305  304  244  192  178 

Number of reported cases

(Click for retrospective incidence data for Cyprus)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  10 
Mumps
ChartChart
 
Pertussis
ChartChart
  16 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cyprus)
Vaccine year result method % card seen                                                
BCG         
DTP1          99*  99*  99*  99*  99*  99* 
DTP3          97  97  99  99  99  97  34 
DTP4         
IPV1          99*  99*  99* 
HepB_BD          95 
HepB3          97  97  96  96  96  89 
Hib3          96  97  96  96  96  32 
JapEnc         
MCV1          90  90  86  86  86  86  29 
MCV2         
MenA         
PCV1          98  98  97  97  97 
PCV2          95  95  93  93  93 
PCV3          81  81 
Pol3          97  97  99  99  99  97  35 
Rota1         
RotaC         
RCV1          90  90  86  86  86 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cyprus)
DTP1
ChartChart
  98  98  99  99  99  98  97  59 
DTP3
ChartChart
  97  97  99  99  99  97  93  34 
HepB3
ChartChart
  97  97  96  96  96  89 
HepB_BD
 
Hib3
ChartChart
  96  97  96  96  96  32 
MCV1
ChartChart
  90  90  86  86  86  86  77  29 
MCV2
ChartChart
  88  88  88  88  88 
PCV3
ChartChart
  81  81 
Pol3
ChartChart
  97  97  99  99  99  97  94  35 
RCV1
ChartChart
  90  90  86  86  86  86  77  29 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Yes Given only to persons with continuous contact with a contagious form of TB
DTaPIPV 2, 4, 6, 15-18 months; 4-6 years; Yes
HepA Yes given on special indications
HepB_Adult Yes Given to high risk groups if were not vaccinated in childhood
HepB_Pediatric 2, 4, 8-12 months; Yes
HIB 2, 4, 6, 12-18 months; Yes
HPV 12-13 years (x2); Yes
Influenza_Adult > 65 years; adults with chronic diseases, health care workers, travelers, pregnant women and other risk groups
Influenza_Pediatric Yes children with chronic diseases
IPV Yes booster dose for travelleres where recommended
MenAC Yes given on special indications
MenC_conj 12-13 months; Yes
MMR 12-15 months; 4-6 years; Yes
Pneumo_conj 2, 4, 12-15 months; Yes
Pneumo_ps Yes risk groups
Td 14-16 years; Yes and adult booster
Typhoid Yes given for travellers when indicated
Varicella 13-18 months, 4-6 years; Yes
YF Yes only given to travellers to endemic areas

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2017  2'017  2'015  2'014  2'013    2'012 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  83  83  83 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 20  20  20  20  17  33  33 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No        No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes        Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.